Eavesdrop On Experts

“I think it’s very likely we’ll get to good drugs even quicker than we’ll get to a good vaccine,” says Peter Doherty, Nobel Prize winner, University of Melbourne Laureate Professor, patron and namesake of the Doherty Institute for Infection and Immunity. “What’s worked for HIV is what we call designer drugs,” Professor Doherty says. “Structural biologists design a chemical which will fit in to the really important part of that [virus] structure for binding to the cell, for instance. That would be a blocker, and that’s an effective drug.” In terms of what we need to do to prepare for a future pandemic caused by an unknown virus, Professor Doherty highlights the work of CEPI, the Coalition for Epidemic Preparedness Innovations. “[CEPI] funded the research of Professor Paul Young and his group at the University of Queensland, who’ve developed the primary Australian COVID-19 vaccine candidate. They developed a platform technology called the protein clamp. When this new virus came along, they were just able to